États-Unis · Bourse & Finance · Investor's Business Daily

Nektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating.

Publié par Investor's Business Daily · États-Unis il y a 12 h

Nektar stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients.

Lire l'article complet sur Investor's Business Daily Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investors.com)

À lire aussi

Calamos Long/Short Equity & Dynamic Income Trust declares $0.14 dividend

NEAR Intents says its identified the hacker, gives 48-hour ultimatum

Business Insider

Tesla rolled out a 'drive away' feature it hopes ‘you never need’

Robotaxi operators will face fines for blocking first responders

‘Playing a dangerous game’: Putin threatens using ‘all its arsenal’ if there is a ‘direct attack on the Russian Federation’

5 Energy ETFs That Have Soared in 2026